Skip to main content
OpenTrials

Clinical trial condition

Wet Age Related Macular Degeneration

Explore clinical trials studying Wet Age Related Macular Degeneration. Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Wet Age Related Macular Degeneration trial results

Active, not recruiting

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

NCT06683742

Conditions
Wet Age Related Macular Degeneration, wAMD
Locations
  • Associated Retina Consultans Gilbert, Arizona, United States
  • Associated Retina Consultants - Phoenix Phoenix, Arizona, United States
  • Phoenix Retina Clinical Trials, LLC Phoenix, Arizona, United States
  • Retina Macula Institute of Arizona Scottsdale, Arizona, United States
View all 113 locations
View Trial Details
Active, not recruiting

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

NCT06668064

Conditions
Wet Age Related Macular Degeneration, wAMD
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Retina Partners of Northwest Arkansas Springdale, Arkansas, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina Vitreous Associates Medical Group Beverly Hills, California, United States
View all 76 locations
View Trial Details
Completed

NT-101 Topical Ophthalmic Solution in Patients With Wet AMD

NCT06704009

Conditions
Eye Diseases, Macular Degeneration, Retinal Degeneration, +3 more
Locations
  • Elman Retina Group Rosedale, Maryland, United States
  • Duke Eye Center Durham, North Carolina, United States
  • Erie Retina Research Erie, Pennsylvania, United States
  • Texas Retina Associates Dallas, Texas, United States
View Trial Details
Completed

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye

NCT01986907

Conditions
Eye Diseases, Macular Degeneration, Retinal Degeneration, +2 more
Locations
  • Novartis Investigative Site Alessandria, AL, Italy
  • Novartis Investigative Site Casale Monferrato, AL, Italy
  • Novartis Investigative Site Ancona, AN, Italy
  • Novartis Investigative Site Acquaviva delle Fonti, BA, Italy
View all 101 locations
View Trial Details
Completed

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

NCT01318941

Conditions
Cardiovascular Diseases, Diabetic Macular Edema, Embolism and Thrombosis, +10 more
Locations
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Concepción del Uruguay, Argentina
  • Novartis Investigative Site Córdoba, Argentina
  • Novartis Investigative Site Guaymallén, Mendoza, Argentina
View all 463 locations
View Trial Details

Related conditions